Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
Diabetes has emerged as a widespread health challenge globally, with type 2 diabetes being the most prevalent among the three types. A study by the National Center for Biotechnology Information (NCBI) in September 2016 predicts that diabetes is set to become the seventh leading cause of death by 2030. Shockingly, 80% of individuals grappling with diabetes reside in developing regions. The surge in diabetes cases is closely linked to escalating obesity rates, along with changes in socioeconomics and nutrition patterns. To put this into perspective, the National Diabetes Statistics Report in 2017 revealed that out of 30.3 million Americans, approximately 1 in 10 people are dealing with diabetes. This alarming statistic underscores the urgent need for effective measures to address and manage the diabetes epidemic.
The impact of diabetes extends beyond the borders of the United States. In Brazil, for instance, data from the International Diabetes Federation in 2017 disclosed that the prevalence of diabetes among adults was 8.7%, translating to a staggering 12,465,800 reported cases. The rise in diabetes cases in various countries underscores the pressing need for robust diagnostic methods to facilitate timely intervention and management. One such diagnostic approach gaining prominence is HbA1c testing. This method involves measuring the levels of glycated hemoglobin in a patient's blood, providing valuable insights into their average blood sugar levels over the past two to three months. As the incidence of diabetes continues to climb, the demand for HbA1c testing has experienced a concurrent upswing. The utility of this testing method in diagnosing diabetes and monitoring its progression has contributed significantly to the growth of the global HbA1c testing market. In conclusion, the escalating prevalence of diabetes, particularly type 2 diabetes, poses a significant health challenge worldwide. The increasing cases in both developed and developing nations emphasize the need for proactive measures, including advanced diagnostic tools like HbA1c testing. As the numbers continue to rise, addressing the diabetes epidemic becomes not only a health priority but also an economic imperative.
Covered Aspects:
| Report Attribute/Metric | Details |
|---|---|
| Market Opportunities | Growing adoption of advanced diagnostic tools and devices coupled with the strategic activities such as partnerships and agreements by the prominent players |
HbA1c Testing Market Highlights:
HbA1c Testing Market Overview
The HbA1c Testing Market Size was valued at USD 1.68 Billion in 2023 and is projected to grow from USD 1.80 Billion in 2024 to USD 4.56 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 13.12% during the forecast period (2024 - 2032). Hemoglobin A1c (HbA1c) is a form of hemoglobin that is bound to glucose. The HbA1c test provides the patient with the average level of blood sugar only for the past 2 to 3 months.
HbA1c is a modified form of hemoglobin that is present in red blood cells. Most of the hemoglobin is in HbA form and during their lifespan, only a small fraction transforms into HbA1. HbA1 is further separated into HbA1a, HbA1b, and HbA1c. A high level of HbA1c is present in the body of diabetes patients as its formation occurs only during a process called glycosylation that converts glucose into glycogen for storage purposes. This HbA1c test results in the blood sugar level of the past 2 to 3 months of the diabetes patient’s body.
Worldwide, diabetes is one of the most prevalent epidemics and there are three types of diabetes. Out of them, type 2 diabetes is the common type. In September 2016, according to the National Center for Biotechnology Information (NCBI) research, diabetes is expected to be the seventh leading cause of death by the year 2030. In 2017, according to the report of the International Diabetes Federation, there are 12,465,800 diabetes cases are reported globally and the prevalence of diabetes in Brazil was 8.7% among adults. Due to these increasing occurrences, various testing methods like HbA1c testing equipment are diagnosed to the patients. This is the major driving factor of the HbA1c testing market growth.
COVID-19 Analysis:
The COVID-19 pandemic affects millions of people and brought the world to a standstill. Diabetic people and the market of HbA1c testing are also impacted by this pandemic. This testing volume was decreased by 66% in March and April 2020. Due to the pandemic, the stay at home orders and social distancing regulations are imposed and thus results in decrement of HbA1c testing volumes convert to postponed testing’s and decline in HbA1c testing frequency. Moreover, in this way or any other reasons, the missing of HbA1c point of care testing leads to adverse impacts of glucose control, clinical outcomes, and diabetes-related medical prices. In this way, the HbA1c testing procedures are impacted by COVID-19 and decline its market growth. Further, post-COVID, the market of HbA1c testing is rapidly increased due to its increased usage.
HbA1c Testing Market Dynamics
Drivers:
Rising per capita disposable income and developing healthcare infrastructure is the major driving factor for the growth of the market. Introducing advanced innovations in treatment options is propelling the growth of the market. Due to poor dietary choices, lack of physical activities, and higher stress levels, the people affected with diabetes are increasing day by day and the physicians are prescribing the HbA1c test fasting to their patients which increases the market growth of the HbA1c testing.
Additionally, the emergence of point of care and other latest innovations that reducing diabetes testing costs is aiding the HbA1c testing market growth. The continuous rise in the geriatric population leads to rising in diabetes patients all over the world. The rising scope of medical tourism in developing countries is boosting the HbA1c testing equipment market.
Restraint:
The testing devices are expensive. In few developing countries, these technologies are less adopted and are limiting the growth of the hemoglobin A1c testing devices market.Â
Opportunities:
Rising adoption of advanced diagnostic tools and devices along with strategic activities like partnerships, and agreements among the prominent key players may create the opportunity to increase the market growth. The emergence of the latest testing procedures and advanced technologies like handheld devices is predicted to provide a lucrative opportunity for the market growth of HbA1c testing. The rising awareness among the people regarding the management of diabetes efficiently is offering the growth of the market.
Challenges:
Manufacturing of these testing devices is cost high which poses a challenge for the market growth. Due to the discrepancies in interpretations, the HbA1c standard range testing result may be inaccurate which is hindering the HbA1c assay market growth.
Study Objectives -
- To provide detailed information about the market of HbA1c testing structure along with various forecast segments and sub-segments for the next 10 years.
- To provide the factors that are affecting the growth of the HbA1c testing market value.
- To analyze the HbA1c testing industry analysis based on porter’s five force analysis, factors-price analysis, supply chain analysis, etc.
- To provide history and forecast revenue segments and sub-segments of the HbA1c testing global market revenue for the main geographies.
- To provide the country-level analysis of the current HbA1c testing market size and future prospective.
- To provide country-level analysis of the HbA1c testing industry growth by region, form, and application.
- To provide a strategic profile of the prominent key players in the market, analyze their core competencies, and draw a market growth of HbA1c testing landscape.
- To track and analyze new product developments, strategic alliances, and global HbA1c testing market research.
HbA1c Testing Market Segment Insights
The market of HbA1c testing has been divided into segments based on technology, product, end-user, and region.
HbA1c Testing Technology Insights
Based on the technology, the global hemoglobin testing market is classified into few types as ion-exchange HPLC, TINIA, enzymatic assay, and others. Out of these, ion-exchange HPLC is holding the largest market share for its high demand in the market. It is the most widely used testing kit that consumes less time, recognizes variants, and is also used in point-of-care settings. TINIA is expected to grow at a significant rate during the review period which offers the benefits like accurate results, cost-effectiveness, and quick-swiftness.
HbA1c Testing Product Insights
The global HbA1c testing machine market based on the product is bifurcated into two types as reagents & kits, and instruments. Further, the instruments are divided into a bench-top device and a handheld device.
HbA1c Testing End-user Insights
By end-user, the global HbA1c testing equipment market is analyzed into hospitals &clinics, diagnostic laboratories, and others. The hospitals &clinics segment is dominating the HbA1c testing market share due to the growing geriatric population worldwide.
HbA1c Testing Region Insights
Regionally, the global Hemoglobin testing machine market is categorized into four main geographies such as Europe, Asia-Pacific, America, and the Middle East & Africa. America is dominating the largest market share for its rising activities like awareness campaigns, research, and joint ventures by public and private organizations in emerging countries like the US and Canada.
HbA1c Testing Market Regional Analysis
Geographically, the HbA1c testing global market is divided into four major regions like Asia-Pacific, Europe, America, and the Middle East & Africa. Out of these regions, America is holding the leading position in the market of HbA1c testing for its rising activities like awareness campaigns, research, and joint ventures by public and private organizations in the US and Canada. Europe is predicted to hold the second-largest market share for their increasing adoption of advanced diagnostic tools and devices coupled with strategic activities like partnerships and agreements by the major key players is accelerating the market growth in this region.
Due to the developing healthcare infrastructure and increasing per capita disposable income, Asia-Pacific is witnessing the fastest-growing region. Due to limited access to healthcare, growing awareness regarding healthcare, and availability of the latest treatments, the Middle East & Africa is witnessing steady growth.
Competitive Landscape
The prominent key players in the HbA1c testing market outlook are the following:
- Bio-Rad Laboratories, Inc. (US)
- Abbott Laboratories (US)
- ARKRAY, Inc. (Japan)
- Danaher Corporation (US)
- Hoffmann-La Roche Ltd (Switzerland)
- Transasia Bio-Medicals (India)
- Siemens Healthineers (US)
- EKF Diagnostics (UK)
- PTS Diagnostics (US)
- Agappe Diagnostics Ltd (India)
- Trinity Biotech PLC (Ireland)
- DiaSys Diagnostic Systems GmbH (Germany)
- CPC Diagnostics Pvt. Ltd. (India)
- Tosoh India Pvt. Ltd (India)
- Rapid Diagnostics Group of Companies (India)
Recent Developments
February 2023:Bio-Rad Laboratories, Inc. (US) launched the D-100 Hemoglobin A1c assay, a high-performance liquid chromatography (HPLC) method offering accurate and precise HbA1c measurement on their D-Series analyzers.Â
August 2022:Transasia Bio-Medicals (India) received approval from the Indian Council of Medical Research (ICMR) for their HbA1c self-testing kit, marking a significant step towards increased accessibility in India.
October 2023:Abbott Laboratories (US) received FDA clearance for the FreeStyle Libre 3 system, a continuous glucose monitoring (CGM) device offering 14-day wear and improved accuracy. While not directly an HbA1c test, CGM data can be used to estimate HbA1c levels.
HbA1c Testing Market Segmentation
Globally, the HbA1c Testing market trends have been segmented into four types based on the technology, product, end-user, and region.
HbA1c Testing Technology Outlook
- Ion-exchange HPLC
- TINIA
- enzymatic assayÂ
- others
HbA1c Testing Product Outlook
- Reagents & kits
- Instruments
HbA1c Testing End-user Outlook
- Hospitals & clinicsÂ
- Diagnostic laboratories
- others
HbA1c Testing Region Outlook
-
North America
-
US
-
Canada
-
Europe
-
Germany
-
France
-
UK
-
Italy
-
Spain
-
Rest of Europe
-
Asia-Pacific
-
China
-
Japan
-
India
-
Australia
-
South Korea
-
Australia
-
Rest of Asia-Pacific
-
-
Rest of the World
-
Middle East
-
Africa
-
Latin America
-
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
